Mesa Laboratories reports Q4 EPS of -1.31 dollars

institutes_icon
PortAI
05-28 20:01

Summary

Mesa Laboratories reported a fourth-quarter basic earnings per share of -$1.31. The company had a gross profit of $38.41 million, a net income of -$7.114 million, and an operating income of $1.469 million for the fourth quarter.

Impact Analysis

  1. Business Overview Analysis
  • business_model: Mesa Laboratories operates in the field of laboratory instrumentation and services. Its core revenue streams likely include sales of lab equipment and related services.
  • market_position: Mesa Laboratories’ position in the market is not explicitly mentioned, but as a specialized laboratory instrument provider, it likely competes with other niche players and larger diversified medical technology companies.
  • recent_events_impact: The significant quarterly loss may impact investor confidence and the company’s ability to invest in future growth.
  1. Financial Statement Analysis
  • income_statement: The negative earnings per share indicate that the company is currently unprofitable. Despite a gross profit, the net income is negative, suggesting high operating costs or other expense challenges.
  • balance_sheet: Specific details on assets, liabilities, and working capital are not provided. However, net losses could indicate potential pressure on the balance sheet if these trends continue.
  • cash_flow: Without explicit cash flow data, it is challenging to assess operational cash generation. The operating income was positive, but not sufficient to cover all expenses.
  • key_financial_ratios:
  • Profitability: ROE and ROA are likely negative due to net losses. Operating margins are under pressure.
  • Liquidity: Without balance sheet data, liquidity ratios can’t be calculated.
  • Solvency: Debt/Equity and Interest Coverage ratios can’t be determined from provided data.
  • Efficiency: Asset and Inventory Turnovers can’t be assessed without more data.
  1. Risks and Opportunities
  • risks: Continued losses may affect Mesa Laboratories’ financial flexibility and investment capability.
  • opportunities: Focusing on cost management and exploring new revenue streams could help improve financial health.
Event Track